reglab/housing_qa huggingface dataset:
MD. Health - General Code Ann. §  17-308 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 3 - Tissue Banks|Section 17-308 - Issuance and Contents of Permit

    (a)    The Secretary shall issue a permit to any applicant who meets the requirements of this subtitle.    (b)    The Secretary shall include on each permit that the Secretary issues:        (1)    The name of the tissue bank;        (2)    The name of its director;        (3)    The name of its owner; and        (4)    The classes of services that the tissue bank may offer.
MD. Health - General Code Ann. §  17-309 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 3 - Tissue Banks|Section 17-309 - Scope of Permit

    While it is effective, a permit authorizes the permit holder:         (1)    To operate or to represent or service the tissue bank named in the permit; and        (2)    To offer and perform the classes of services set forth in the permit.
MD. Health - General Code Ann. §  17-311 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 3 - Tissue Banks|Section 17-311 - Denials, Suspensions, and Revocations

    (a)    The Secretary may deny a permit to any applicant or suspend or revoke a permit or the authority to offer or perform any class of service that the permit sets forth, if the tissue bank or its director fails to meet the requirements that the Secretary adopts under this subtitle.    (b)    Except as otherwise provided in the Administrative Procedure Act, before the Secretary takes any action under this section, the Secretary shall give the applicant or permit holder notice and an opportunity for a hearing.
MD. Health - General Code Ann. §  17-312 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 3 - Tissue Banks|Section 17-312 - Operating Without Permit

    (a)    A person may not operate a tissue bank in this State unless the person holds a permit issued by the Secretary.    (b)    A permit holder may not offer or perform any class of service of a tissue bank that is not authorized by the permit.
MD. Health - General Code Ann. §  17-313 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 3 - Tissue Banks|Section 17-313 - Representing or Servicing Tissue Banks

    (a)    A person may not represent or service any tissue bank, regardless of location, unless the tissue bank and its director meet the standards and qualifications that the Secretary adopts under this subtitle.    (b)    A person may not represent or service in this State any tissue bank that is not in this State unless the person holds a permit to represent or service the tissue bank.
MD. Health - General Code Ann. §  17-314 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 3 - Tissue Banks|Section 17-314 - Penalties

    A person who violates any provision of this subtitle is guilty of a misdemeanor and on conviction is subject to a fine not exceeding $100 for the first offense and not exceeding $500 for each subsequent conviction for a violation of the same provision. Each day a violation is continued after the first conviction is a subsequent offense.
MD. Health - General Code Ann. §  17-501 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 5 - Cholesterol Testing|Section 17-501 - Definitions

    (a)    In this subtitle the following words have the meanings indicated.    (b)    “Cholesterol testing” includes collecting a test specimen, testing to detect the amount of cholesterol in an individual’s blood, and the reporting of test results.    (c)    “Permit” means a permit issued by the Secretary to a person who:        (1)    Offers to provide, with or without charge, a test to detect the amount of cholesterol in an individual’s blood; and        (2)    Conducts the test outside a permanently located medical laboratory issued a permit or excepted from a permit under Subtitle 2 of this title.
MD. Health - General Code Ann. §  17-502 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 5 - Cholesterol Testing|Section 17-502 - Permits Generally Required

    (a)    Except as provided under subsection (b) of this section and § 17-503 of this subtitle, a person shall obtain a permit from the Department before:        (1)    Offering to provide a test to detect the amount of cholesterol in an individual’s blood; and        (2)    Conducting the cholesterol test outside a permanently located medical laboratory issued a permit or excepted from a permit under Subtitle 2 of this title.    (b)    A cholesterol testing permit is not required under this subtitle for a medical laboratory that:        (1)    Is licensed under Subtitle 2 of this title; and        (2)    As set forth in the license, provides tests or services in the discipline of chemistry or health awareness.
MD. Health - General Code Ann. §  17-503 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 5 - Cholesterol Testing|Section 17-503 - Submission of Plans

    (a)    Any local or county health department may submit to the Secretary its cholesterol testing plan for review.    (b)    (1)    The Secretary shall review all submissions under this section as soon as reasonably possible after the submission in order to determine whether it meets the standards necessary for adequate off-site cholesterol testing in accordance with this subtitle.        (2)    If a plan submitted under this section meets the standards of this subtitle, the Secretary may waive the permit requirements of the subtitle and permit the submitting local or county health department to conduct cholesterol testing under this subtitle for a period of 12 months, provided that:            (i)    The submission adequately describes the cholesterol testing plan for the effective 12 months;            (ii)    The local or county health department provides all information that the Secretary may reasonably require to determine compliance with this section;            (iii)    The local or county health department agrees to make records available and submit reports to the Secretary as the Secretary may require;            (iv)    Changes and amendments to the plan are submitted 60 days prior to proposed implementation; and            (v)    All changes and amendments to the plan are approved by the Secretary.        (3)    If a plan submitted under this section does not meet the standards of this subtitle, or if the information supplied in the submission is considered by the Secretary to be insufficient for a determination, the submitting local or county health department shall apply for a permit in accordance with this subtitle.    (c)    The Secretary may cancel a waiver granted under this section at any time if the Secretary finds that the local or county health department does not continue to meet the standards of this subtitle.
MD. Health - General Code Ann. §  17-504 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 5 - Cholesterol Testing|Section 17-504 - Regulations; Certification of Personnel Not Required

    (a)    The Secretary shall adopt regulations to implement the provisions of this subtitle, including regulations that assure the citizens of this State that cholesterol testing conducted outside a permanently located medical laboratory meets appropriate national standards of quality assurance.    (b)    The regulations shall include:        (1)    Personnel training standards, including requirements for reasonable training, experience, and competency in:            (i)    Simple procedures used in drawing blood for cholesterol testing; and            (ii)    The operation of blood chemical analyzers used for cholesterol screening;        (2)    Quality assurance standards;        (3)    Standards for counseling and referral procedures;        (4)    Standards for releasing and reporting test results; and        (5)    A prohibition on the payment of any sum to any person for bringing or referring a patient.    (c)    (1)    The Secretary may not require that cholesterol testing personnel that conduct cholesterol tests under this subtitle be certified in a medical laboratory specialty.        (2)    All cholesterol testing conducted under this subtitle shall be overseen by a supervisor knowledgeable in all aspects of cholesterol testing services.
MD. Health - General Code Ann. §  17-505 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 5 - Cholesterol Testing|Section 17-505 - Qualifications for Permit

    To qualify for a permit, an applicant shall meet the requirements of this subtitle and any regulation that the Secretary adopts under this subtitle.
MD. Health - General Code Ann. §  17-506 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 5 - Cholesterol Testing|Section 17-506 - Applications for Permits

    An applicant for a permit shall submit an application to the Secretary on the form that the Secretary requires.
MD. Health - General Code Ann. §  17-507 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 5 - Cholesterol Testing|Section 17-507 - Issuance and Contents of Permit

    (a)    The Secretary shall issue a permit to any applicant who meets the requirements of this subtitle.    (b)    The Secretary shall include on each permit:        (1)    The name of the permittee;        (2)    The address of the permittee; and        (3)    The expiration date of the permit.
MD. Health - General Code Ann. §  17-509 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 5 - Cholesterol Testing|Section 17-509 - Denials, Suspensions, or Revocations

    (a)    The Secretary may deny a permit to an applicant or suspend or revoke an existing permit for failure to comply with the provisions of this subtitle and any regulation adopted under this subtitle.    (b)    Except as otherwise provided in the Administrative Procedure Act, before the Secretary takes any action under this section, the Secretary shall give the applicant or permit holder notice and an opportunity for a hearing.
MD. Health - General Code Ann. §  17-510 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 5 - Cholesterol Testing|Section 17-510 - Testing Without Permit; Nontransferability of Permit

    (a)    Except as otherwise provided in this title, a person may not offer cholesterol testing in this State unless the person holds a permit from the Secretary.    (b)    The permit is not transferable.
MD. Health - General Code Ann. §  17-511 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 5 - Cholesterol Testing|Section 17-511 - Violations; Penalties

    A person who violates any provision of this subtitle is guilty of a misdemeanor and on conviction is subject to a fine not exceeding $100 for the first offense and not exceeding $500 for each subsequent conviction for a violation of the same provision. Each day a violation is continued after the first conviction is a subsequent offense.
MD. Health - General Code Ann. §  17-601 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 6 - Biological Agents Registry Program|Section 17-601 - Definitions

    (a)    In this subtitle the following words have the meanings indicated.    (b)    “Biological agent” means any biological agent as defined in Title 42, Part 73 of the Code of Federal Regulations, or Title 9, Part 121 of the Code of Federal Regulations.    (c)    “Maryland Institute for Emergency Medical Services Systems” means the unit described in § 13-503 of the Education Article.    (d)    “Person” includes State and federal units of government.    (e)    “Program” means the Biological Agents Registry Program.
MD. Health - General Code Ann. §  17-602 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 6 - Biological Agents Registry Program|Section 17-602 - Registry Program

    (a)    There is a Biological Agents Registry Program in the Department.    (b)    The Biological Agents Registry shall:        (1)    Identify the biological agents possessed and maintained by any person in this State; and        (2)    Contain other information as required by regulations adopted by the Department.    (c)    The Department shall adopt regulations for the implementation of the Program that:        (1)    Determine and list the biological agents required to be reported under this subtitle;        (2)    Designate the persons required to make reports and the specific information required to be reported;        (3)    Designate time limits for reporting, the form of reports, and the persons to whom reports are to be submitted;        (4)    Require local jurisdictions to be informed of the location and nature of each biological agent in the Registry that is located within the local jurisdiction;        (5)    Provide for the release of information in the Biological Agents Registry to:            (i)    State and federal law enforcement agencies and the Centers for Disease Control and Prevention pursuant to a communicable disease investigation commenced or conducted by the Department or other State or federal law enforcement agency having investigatory authority, or in connection with any investigation involving release, theft, or loss of biological agents;            (ii)    The Maryland Emergency Management Agency and the Maryland Department of the Environment for the purposes of planning for the protection of the public in relation to the release of a biological agent and the prevention of a release of a biological agent; and            (iii)    The Maryland Institute for Emergency Medical Services Systems for the purposes of providing certain specified information to:                1.    A police officer, as defined in § 3–201(f) of the Public Safety Article, responding to an emergency; and                2.    A fire, rescue, or emergency medical services entity, as defined in § 7–101 of the Public Safety Article, performing emergency services, responding to a fire or other emergency, or dispatched on a call for emergency services;        (6)    Establish a system of safeguards that requires persons possessing, maintaining, and transferring biological agents subject to this subtitle to comply with the same federal standards that apply to persons registered to transfer the same agents under federal law; and        (7)    Establish a process for persons that possess and maintain biological agents to alert appropriate authorities of unauthorized possession or attempted possession of biological agents.
MD. Health - General Code Ann. §  17-603 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 6 - Biological Agents Registry Program|Section 17-603 - Reporting Requirements

    (a)    Except as provided in subsection (b) of this section, any person that possesses and maintains any biological agent shall report to the Department the information required by the Department for inclusion in the Biological Agents Registry.    (b)    Subsection (a) of this section does not apply to a biological agent or a certified laboratory or facility that is exempt from the requirements for the interstate shipment of etiologic agents under Title 42, Part 72.6(h) or Part 72, Appendix A of the Code of Federal Regulations.
MD. Health - General Code Ann. §  17-604 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 6 - Biological Agents Registry Program|Section 17-604 - Confidentiality

    (a)    Except as otherwise provided in this subtitle, information prepared for or maintained in the Biological Agents Registry shall be confidential and is not subject to Title 4 of the General Provisions Article.    (b)    Release of information from the Registry as authorized by regulations adopted under § 17-602(c) of this subtitle shall not render the information released a public record.    (c)    A person or entity to whom specified information has been released from the Registry as authorized by regulations adopted under § 17-602(c) of this subtitle may not release the information unless the release is approved by the Biological Agents Registry Program.
MD. Health - General Code Ann. §  17-605 (2021)
2021 Maryland Statutes|Health - General|Title 17 - Laboratories|Subtitle 6 - Biological Agents Registry Program|Section 17-605 - Penalty

    (a)    A person who violates any provision of this subtitle is guilty of a misdemeanor and on conviction is subject to a fine not exceeding $100 for the first offense and not exceeding $500 for each subsequent conviction for a violation of the same provision.    (b)    Each day a violation is continued after the first conviction is a subsequent offense.
MD. Health - General Code Ann. §  18-101 (2021)
2021 Maryland Statutes|Health - General|Title 18 - Disease Prevention|Subtitle 1 - General Responsibilities of Secretary|Section 18-101 - Investigations Into Causes of Disease and Mortality

    The Secretary shall investigate:         (1)    The causes of disease and, particularly, the causes of epidemics;        (2)    The causes of mortality; and        (3)    The influence of locality, employment, habit, and other conditions on health.
MD. Health - General Code Ann. §  18-102 (2021)
2021 Maryland Statutes|Health - General|Title 18 - Disease Prevention|Subtitle 1 - General Responsibilities of Secretary|Section 18-102 - Infectious and Contagious Diseases

    (a)    The Secretary shall adopt rules and regulations necessary to prevent:        (1)    The introduction of an infectious or contagious disease into this State or other disease that endangers public health in this State; or        (2)    The spread of an infectious or contagious disease or other disease that endangers public health in this State.    (b)    When the Secretary has reason to believe that an infectious or contagious disease or other disease that endangers public health exists within the State, the Secretary shall:        (1)    Investigate the suspected disease; and        (2)    Act properly to prevent the spread of the disease.    (c)    (1)    Except as provided in paragraph (2) of this subsection, an individual enrolled in an institution of higher education who resides in on-campus student housing shall be vaccinated against meningococcal disease.        (2)    An individual is exempt from the vaccination requirement in paragraph (1) of this subsection if:            (i)    The institution of higher education provides detailed information on the risks associated with meningococcal disease and the availability and effectiveness of any vaccine to:                1.    The individual, if the individual is 18 years of age or older; or                2.    The individual’s parent or guardian, if the individual is a minor; and            (ii)    1.    The individual is 18 years of age or older and the individual signs a written waiver in a form approved by the Secretary stating that the individual has received and reviewed the information provided and has chosen not to be vaccinated against meningococcal disease; or                2.    The individual is a minor and the individual’s parent or guardian signs a written waiver in a form approved by the Secretary stating that the parent or guardian has received and reviewed the information provided and has chosen to not have the individual vaccinated against meningococcal disease.        (3)    Nothing in this subsection shall be construed to require any institution of higher education to provide or pay for vaccinations against meningococcal disease.        (4)    The Secretary, in consultation with the Maryland Higher Education Commission, shall adopt regulations necessary to implement this subsection.    (d)    The Secretary may enter on and inspect private property to determine the presence, cause, and source of an infectious or contagious disease or other disease that endangers public health in this State.
MD. Health - General Code Ann. §  18-103 (2021)
2021 Maryland Statutes|Health - General|Title 18 - Disease Prevention|Subtitle 1 - General Responsibilities of Secretary|Section 18-103 - Communicable Diseases

    (a)    The Secretary shall:        (1)    Obtain accurate and complete reports on communicable diseases in this State;        (2)    Determine the prevalence of each communicable disease; and        (3)    Devise means to control communicable diseases.    (b)    The Secretary shall publish monthly a communicable disease bulletin for health officers and other related health professionals.
MD. Health - General Code Ann. §  18-104 (2021)
2021 Maryland Statutes|Health - General|Title 18 - Disease Prevention|Subtitle 1 - General Responsibilities of Secretary|Section 18-104 - Cancer

    (a)    The Secretary shall investigate, if feasible, means to prevent, treat, and cure cancer.    (b)    The Secretary may adopt procedures to obtain information about cancers that are caused by carcinogens and about the incidence of these cancers.
MD. Health - General Code Ann. §  18-105 (2021)
2021 Maryland Statutes|Health - General|Title 18 - Disease Prevention|Subtitle 1 - General Responsibilities of Secretary|Section 18-105 - Toxic Substances

    The Secretary may adopt procedures to obtain information about diseases that are caused by toxic substances and about the incidence of these diseases.
MD. Health - General Code Ann. §  18-107 (2021)
2021 Maryland Statutes|Health - General|Title 18 - Disease Prevention|Subtitle 1 - General Responsibilities of Secretary|Section 18-107 - Diseases of Pregnancy and Childhood

    (a)    The Secretary shall:        (1)    Devise and institute means to prevent and control morbidity and mortality associated with:            (i)    Pregnancy;            (ii)    Childbirth;            (iii)    Infancy; and            (iv)    Early childhood; and        (2)    Promote the welfare and hygiene of maternity and infancy.    (b)    (1)    The Secretary shall establish a Morbidity, Mortality, and Quality Review Committee in the Department.        (2)    The Committee shall:            (i)    Conduct confidential and anonymous case reviews of morbidity and mortality associated with pregnancy, childbirth, infancy, and early childhood; and            (ii)    Develop and implement interventions to improve the system of care for pregnancy, childbirth, infancy, and early childhood based on the findings from case reviews conducted under item (i) of this paragraph.        (3)    (i)    The Secretary shall adopt regulations to implement the requirements of this section.            (ii)    The regulations shall include:                1.    The types of case reviews conducted by the Committee;                2.    The confidentiality of case reviews;                3.    A description of the types of records and information needed by the Committee to conduct the case reviews under this section; and                4.    The process for obtaining records, including patient medical records, and any other necessary information in accordance with § 4–305(b) of this article.    (c)    This section does not enable the Secretary:        (1)    To take charge of a child if the parent, guardian, or other person who has custody of the child objects; or        (2)    To treat the child for a disease without the consent of the parent, guardian, or other person who has custody of the child.
MD. Health - General Code Ann. §  18-401 (2021)
2021 Maryland Statutes|Health - General|Title 18 - Disease Prevention|Subtitle 4 - Miscellaneous Provisions|Section 18-401 - Drugs and Vaccines

    (a)    A person lawfully administering a drug or vaccine shall have the immunity from liability described under § 5-629(b) of the Courts and Judicial Proceedings Article.    (b)    If the Secretary or a designee of the Secretary finds that a proposed immunization project would conform to good medical and public health practice and gives written approval for the project to be administered in this State, a physician, nurse, or other person participating in the project shall have the immunity from liability described under § 5-629(c) of the Courts and Judicial Proceedings Article.